In last trading session, Tourmaline Bio Inc (NASDAQ:TRML) saw 0.85 million shares changing hands with its beta currently measuring 2.39. Company’s recent per share price level of $20.65 trading at $0.31 or 1.52% at ring of the bell on the day assigns it a market valuation of $529.52M. That closing price of TRML’s stock is at a discount of -133.95% from its 52-week high price of $48.31 and is indicating a premium of 41.31% from its 52-week low price of $12.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.16 million shares which gives us an average trading volume of 229.33K if we extend that period to 3-months.
Tourmaline Bio Inc (NASDAQ:TRML) trade information
Upright in the green during last session for gaining 1.52%, in the last five days TRML remained trading in the red while hitting it’s week-highest on Monday, 12/16/24 when the stock touched $20.65 price level, adding 9.43% to its value on the day. Tourmaline Bio Inc’s shares saw a change of -21.12% in year-to-date performance and have moved -5.32% in past 5-day. Tourmaline Bio Inc (NASDAQ:TRML) showed a performance of -13.96% in past 30-days. Number of shares sold short was 1.63 million shares which calculate 8.15 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have assigned a consensus price target of 50 to the stock, which implies a rise of 58.7% to its current value. Analysts have been projecting 50 as a low price target for the stock while placing it at a high target of 50. It follows that stock’s current price would drop -142.13% in reaching the projected high whereas dropping to the targeted low would mean a loss of -142.13% for stock’s current value.
Tourmaline Bio Inc (TRML) estimates and forecasts
Statistics highlight that Tourmaline Bio Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 40.48% of value to its shares in past 6 months, showing an annual growth rate of 66.29% while that of industry is 16.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -19.23% during past 5 years.
